Absolute Value Group (|AV|) is an independent clearinghouse for Alzheimer’s disease (AD) clinical expertise, with a mission of accelerating innovation for individuals and families living with AD. In the fall of 2025, we launched a first-ever community for clinical AD experts across the US – yielding ongoing, iterative, deepening peer dialogue around emerging clinical topics. Through our patent-pending methodology, we generate continual, deepening insight into real-world clinical decision making, with breadth and speed that benefits industry clients and other constituents. The result is living, longitudinal intelligence, accumulating institutional knowledge and timely insights mined more cost-effectively than through traditional means of thought leader engagement. As we address these previously-unmet needs in a synergistic way, we serve as a trusted broker to turns negatives into positives and deliver “absolute value” to stakeholders across the AD ecosystem.